[Optimal surveillance intensity of cystoscopy in intermediate-risk non-muscle invasive bladder cancer].

Wang, F; Qin, C P; DU, Y Q; Liu, S J; Li, Q; Xu, T

Wang, F; Qin, C P; DU, Y Q; Liu, S J; Li, Q; Xu, T.

Afiliación

Wang F; Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Qin CP; Department of Urology, Peking University People's Hospital, Beijing 100044, China.
DU YQ; Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Liu SJ; Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Li Q; Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Xu T; Department of Urology, Peking University People's Hospital, Beijing 100044, China.

Beijing Da Xue Xue Bao Yi Xue Ban ; 54(4): 669-673, 2022 Aug 18.

Article en Zh | MEDLINE | ID: mdl-35950390

Asunto(s)

Cistoscopía; Neoplasias de la Vejiga Urinaria; Anciano; Progresión de la Enfermedad; Femenino; Humanos; Masculino; Recurrencia Local de Neoplasia/diagnóstico; Estudios Retrospectivos; Neoplasias de la Vejiga Urinaria/diagnóstico; Neoplasias de la Vejiga Urinaria/patología; Neoplasias de la Vejiga Urinaria/cirugía

Palabras clave

Bladder cancer; Cystoscopy; Follow-up; Surveillance intensity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistoscopía Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male Idioma: Zh Revista: Beijing Da Xue Xue Bao Yi Xue Ban Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google